tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CUE Stock Latest News

Cue Biopharma to present new in vitro data for CUE-401
The FlyCue Biopharma to present new in vitro data for CUE-401
6d ago
CUE
Cue Biopharma Sets 2026 Annual Meeting, Proposal Deadlines
PremiumCompany Announcements
Cue Biopharma Sets 2026 Annual Meeting, Proposal Deadlines
24d ago
8K
CUE
Cue Biopharma announces preclinical safety, tolerability data for CUE-401
PremiumThe Fly
Cue Biopharma announces preclinical safety, tolerability data for CUE-401
26d ago
CUE
Cue Biopharma Names Lucinda Warren Chief Financial Officer
PremiumCompany Announcements
Cue Biopharma Names Lucinda Warren Chief Financial Officer
1M ago
8K
CUE
Cue Biopharma appoints Warren as chief financial and business officer
PremiumThe Fly
Cue Biopharma appoints Warren as chief financial and business officer
1M ago
CUE
Cue Biopharma’s CUE-101 Trial Hits Completion: What It Means for Cancer Investors
PremiumCompany AnnouncementsCue Biopharma’s CUE-101 Trial Hits Completion: What It Means for Cancer Investors
2M ago
CUE
Cue Biopharma Announces $10 Million Public Equity Offering
Premium
Company Announcements
Cue Biopharma Announces $10 Million Public Equity Offering
3M ago
8K
CUE
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering
Premium
The Fly
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering
3M ago
CUE
Cue Biopharma offers to sell common stock, no amount given
PremiumThe Fly
Cue Biopharma offers to sell common stock, no amount given
3M ago
CUE
Cue Biopharma Releases Updated Corporate Presentation
PremiumCompany Announcements
Cue Biopharma Releases Updated Corporate Presentation
4M ago
8K
CUE
Cue Biopharma Announces CMO Departure
PremiumCompany Announcements
Cue Biopharma Announces CMO Departure
4M ago
8K
CUE
Cue Biopharma, ImmunoScape enter exclusive in-licensing deal
PremiumThe Fly
Cue Biopharma, ImmunoScape enter exclusive in-licensing deal
4M ago
CUE
Cue Biopharma Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsCue Biopharma Reports Q3 2025 Financial Results
4M ago
CUE
Cue Biopharma reports Q3 EPS (7c), consensus (9c)
Premium
The Fly
Cue Biopharma reports Q3 EPS (7c), consensus (9c)
4M ago
CUE
Cue Biopharma, ImmunoScape enter strategic collaboration, license agreement
Premium
The Fly
Cue Biopharma, ImmunoScape enter strategic collaboration, license agreement
4M ago
CUE
Cue Biopharma Partners with ImmunoScape for Cell Therapy
PremiumCompany Announcements
Cue Biopharma Partners with ImmunoScape for Cell Therapy
4M ago
8K
CUE
Cue Biopharma Appoints Usman Azam as New CEO
PremiumCompany Announcements
Cue Biopharma Appoints Usman Azam as New CEO
6M ago
8K
CUE
Cue Biopharma appoints Usman Azam as CEO
PremiumThe Fly
Cue Biopharma appoints Usman Azam as CEO
6M ago
CUE
Cue Biopharma initiated with a Buy at Lucid Capital
PremiumThe Fly
Cue Biopharma initiated with a Buy at Lucid Capital
7M ago
CUE
Cue Biopharma’s Q2 2025: Strategic Advances and Financial Highlights
PremiumCompany AnnouncementsCue Biopharma’s Q2 2025: Strategic Advances and Financial Highlights
7M ago
CUE
Cue Biopharma announces initiation of investigator sponsored trial of CUE-102
Premium
The Fly
Cue Biopharma announces initiation of investigator sponsored trial of CUE-102
7M ago
CUE
Cue Biopharma provides clinical update on CUE-101, saw ORR of 50%
Premium
The Fly
Cue Biopharma provides clinical update on CUE-101, saw ORR of 50%
8M ago
CUE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >